Erytech Pharma SA (ERYP):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Erytech Pharma SA (ERYP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7838
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Erytech Pharma SA (Erytech) is a clinical-stage biopharmaceutical company that provides development of therapies for rare forms of cancer and orphan diseases. The company develops pipeline of product candidates through its proprietary ERYCAPS platform. It offers product candidates which are intended for the treatment of acute myeloid leukemia, acute lymphoblastic leukemia, pancreatic cancer and non hodgkin lymphoma, among others. Erytech provides pipeline products such as eryasp, erymet, erymmune, and others. The company also develops other product candidates which uses encapsulated enzymes to induce tumor starvation. Its technology platform ERYCAPS uses red blood cells to discover therapeutic compounds. Erytech is headquartered in Lyon, France.

Erytech Pharma SA (ERYP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Erytech Pharma SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Erytech Pharma SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Erytech Pharma SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Erytech Pharma SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Erytech Pharma SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Erytech Pharma SA, Medical Equipment, Deal Details 10
Venture Financing 10
Erytech Pharma Raises USD3.95 Million in Venture Financing 10
Erytech Pharma Secures USD19.24 Million in Venture Funding 11
Equity Offering 12
Erytech Pharma Raises USD125 Million in IPO of American Depository Shares 12
Erytech Pharma Raises USD15.9 Million in Private Placement of Shares 14
Erytech Pharma Raises USD74.7 Million in Private Placement of Shares 15
Erytech Pharma Raises USD11 Million in Private Placement of Shares 16
Erytech Pharma Raises USD27 Million in Private Placement of Shares 17
Erytech Pharma Raises USD38 Million in Private Placement of Shares 19
Erytech Pharma SA – Key Competitors 20
Erytech Pharma SA – Key Employees 21
Erytech Pharma SA – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Sep 10, 2018: ERYTECH Pharma announces first half of 2018 financial results 23
May 14, 2018: Erytech Reports First Quarter 2018 Financial Results and Provides Business Update 25
Mar 12, 2018: ERYTECH Provides Business Update and Reports Financial Results for Full Year 2017 26
Sep 11, 2017: ERYTECH Reports First Half 2017 Financial Results and Provides Business Update 28
May 18, 2017: ERYTECH Provides Business Update and Financial Highlights For Q1 2017 31
Corporate Communications 32
May 14, 2018: Erytech Strengthens Executive Team With the Appointment of Alex Dusek as VP of Commercial Strategy 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Erytech Pharma SA, Medical Equipment, Key Facts, 2017 2
Erytech Pharma SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Erytech Pharma SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Erytech Pharma SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Erytech Pharma SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Erytech Pharma SA, Deals By Market, 2012 to YTD 2018 8
Erytech Pharma SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Erytech Pharma Raises USD3.95 Million in Venture Financing 10
Erytech Pharma Secures USD19.24 Million in Venture Funding 11
Erytech Pharma Raises USD125 Million in IPO of American Depository Shares 12
Erytech Pharma Raises USD15.9 Million in Private Placement of Shares 14
Erytech Pharma Raises USD74.7 Million in Private Placement of Shares 15
Erytech Pharma Raises USD11 Million in Private Placement of Shares 16
Erytech Pharma Raises USD27 Million in Private Placement of Shares 17
Erytech Pharma Raises USD38 Million in Private Placement of Shares 19
Erytech Pharma SA, Key Competitors 20
Erytech Pharma SA, Key Employees 21
Erytech Pharma SA, Subsidiaries 22

List of Figures
Erytech Pharma SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Erytech Pharma SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Erytech Pharma SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Erytech Pharma SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Erytech Pharma SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Erytech Pharma SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Erytech Pharma SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Erytech Pharma SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Erytech Pharma SA (ERYP):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Siegfried Holding AG (SFZN):製薬・医療:M&Aディール及び事業提携情報
    Summary Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding interm …
  • Petroleos Mexicanos:企業の戦略・SWOT・財務情報
    Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report Summary Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Plains All American Pipeline LP (PAA):企業の財務・戦略的SWOT分析
    Plains All American Pipeline LP (PAA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Kilitch Drugs India Ltd (KILITCH):製薬・医療:M&Aディール及び事業提携情報
    Summary Kilitch Drugs India Ltd (Kilitch) is a pharmaceutical company that manufactures and markets antibacterial parenteral formulations and other pharmaceutical products. The company offers products such as parenterals and nasal products, oral, effervesscent, nutritional products, medical device, …
  • ProMIS Neurosciences Inc (PMN):医療機器:M&Aディール及び事業提携情報
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, helps in pred …
  • MallInckrodt Plc (MNK)-製薬・医療分野:企業M&A・提携分析
    Summary Mallinckrodt Plc (Mallinckrodt) is a healthcare products provider that offers generics and active pharmaceutical ingredients. The company offers generic products which include addiction treatment products, compounding powders, unit dose products and resource tool kits. Its active pharmaceuti …
  • Second Sight Medical Products Inc (EYES):企業の財務・戦略的SWOT分析
    Summary Second Sight Medical Products Inc (Second Sight) is a medical device company that develops, manufactures and markets implantable visual prosthetics for blind individuals. The company offers Argus II retinal prosthesis system, a device that restores some functional vision for people suffering …
  • Emera Inc:発電所・企業SWOT分析
    Emera Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • Aptevo Therapeutics Inc (APVO):企業の財務・戦略的SWOT分析
    Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Triumph Group Inc:戦略・SWOT・企業財務分析
    Triumph Group Inc - Strategy, SWOT and Corporate Finance Report Summary Triumph Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Caixa Economica Montepio Geral:企業の戦略・SWOT・財務分析
    Caixa Economica Montepio Geral - Strategy, SWOT and Corporate Finance Report Summary Caixa Economica Montepio Geral - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Acadia Pharmaceuticals Inc (ACAD)-製薬・医療分野:企業M&A・提携分析
    Summary Acadia Pharmaceuticals Inc (Acadia) discovers, develops and commercializes small molecule drugs for the treatment of central nervous system disorders. The company’s lead product Nuplazid (pimavanserin) is an FDA approved drug for the treatment of Parkinson’s disease psychosis. Acadia also de …
  • Petropavlovsk PLC:企業の戦略・SWOT・財務情報
    Petropavlovsk PLC - Strategy, SWOT and Corporate Finance Report Summary Petropavlovsk PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Karus Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Karus Therapeutics Ltd (Karus) is a drug development company that designs and develops cancer therapies. The company offers small molecule drugs with immunotherapy for the treatment of hematological and solid tumors. Its pipeline products include KA2507 and KA2237 inhibitors. Karus’ KA2507 i …
  • PolyNovo Biomaterials Pty Ltd:企業の製品パイプライン分析2018
    Summary PolyNovo Biomaterials Pty Ltd (PolyNovo), a subsidiary of PolyNovo Ltd is a medical technology company that develops, designs and manufactures controlled bioeroding tissue and orthopedic solutions. The company’s Novosorb polymers are based on polyurethanes, a polymer family used in medical a …
  • Viridian Energy Supply Ltd:企業の戦略的SWOT分析
    Viridian Energy Supply Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Clean Harbors Inc (CLH):石油・ガス:M&Aディール及び事業提携情報
    Summary Clean Harbors Inc (Clean Harbors) is a provider of environmental, industrial and energy services. The company offers waste disposal and recycling, emergency response, chemical packing, field services, production services, exploration services, directional boring, lodging services and onsite …
  • Arcadia Group Limited:企業の戦略・SWOT・財務分析
    Arcadia Group Limited - Strategy, SWOT and Corporate Finance Report Summary Arcadia Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Oncodesign SA (ALONC):企業の財務・戦略的SWOT分析
    Summary Oncodesign SA (Oncodesign) is a bio pharmaceutical company that discovers drugs to treat diseases with unmet medical needs. It is investigating LRRK2 inhibitor to treat Parkinson’s disease, RIPK2 inhibitor against autoimmune diseases, MNK1/2 inhibitor targeting cancer. The company offers dru …
  • Marquard & Bahls AG:企業の戦略的SWOT分析
    Marquard & Bahls AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆